NetScientific News

RNS Announcements

TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting …

TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting …

NetScientific plc (“NetScientific” or the “Company”)   Result of General Meeting NetScientific plc (AIM:NSCI), the transatlantic healthcare IP commercialisation group, is pleased to announce at its General Meeting held …

TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting …

NetScientific plc (“NetScientific” or the “Company”)    Issue of Equity NetScientific plc (AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that to ensure that the number of Interim …

NetScientific plc (“NetScientific” or the “Company”) PDS Biotechnology Corporation Announces Closing of Approx. $19 Million Public Offering and Full Exercise of Underwriter’s Option to Purchase Additional Shares NetScientific …

NetScientific plc (“NetScientific” or the “Company”) Sofant Technologies Ltd secures £2.3m in an oversubscribed funding round led by EMV Capital NetScientific plc (AIM:NSCI), the transatlantic healthcare IP commercialisation …

NetScientific plc (“NetScientific” or the “Company”) PDS Biotechnology Corporation Announces Pricing of $16.5 Million Public Offering of Common Stock NetScientific plc (AIM:NSCI), the transatlantic healthcare IP commercialisation group, …

NetScientific plc (“NetScientific” or the “Company”) PDS Biotechnology Corporation Announces Proposed Public Offering of Common Stock NetScientific plc (AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that its …

NetScientific plc (“NetScientific” or the “Company”)   Posting of shareholder circular   Further to its announcement of 5 August 2020, NetScientific plc (AIM:NSCI), the transatlantic healthcare IP commercialisation group, …

TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting …

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR …

Subscribe to News via Email

Enter your email address to subscribe to Netscientic News and receive notifications by email.

Media

Francois Martelet, chief executive of NetScientific PLC (LON:NSCI) caught up with Proactive’s Andrew Scott to update on developments within the IP commercialisation specialist’s portfolio. Francois Martelet, chief executive …

London, UK – 05 January 2018 – NetScientific plc (AIM:NSCI), the transatlantic healthcare IP commercialisation group, today announces that its management team will attend the following key investor …

  London, UK – 08 December 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group announces that Francois Martelet, Chief Executive Officer, will be …

François Martelet M.D Netscientific Chief Executive Officer speaks about Netscientific transatlantic healthcare technology group. NetScientific is a transatlantic healthcare IP commercialisation group. We fund and develop companies …

NetScientific plc (LON:NSCI) chief executive and chairman Francois Martelet hailed recent news from portfolio company Vortex Biosciences as a “very important” milestone. Vortex has been awarded a …

Biomedical and healthcare incubator NetScientific PLC (LON:NSCI) had a busy first half to the year, focusing on “execution, execution, execution”, according to chief executive officer François Martelet. …

NetScientific Portfolio News

News_1 - NetScientific